Back Bay Life Science Advisors Announces Team Expansion and Promotions

Back Bay Life Science Advisors, the leading integrated strategy and investment banking firm for global life science companies and investors, announces the ongoing expansion of our strategy consulting team. Our Boston-based group recently welcomed:

  • Jason Kehrl, Ph.D. as Senior Consultant – Dr. Kehrl brings the Back Bay team extensive experience in drug pricing, market access, and drug franchise portfolio strategy.

  • Mavra Nasir, Ph.D. as Consultant – Dr. Nasir has expertise in biostatistics, machine learning, and clinical study design.

  • Crystal Hsu as Consultant - Ms. Hsu guides biopharma brands on drug pricing and market access.

  • Corinne Nawn, Ph.D. as Consultant– Dr. Nawn brings extensive expertise in biomedical engineering.

  • Kyle O'Neil as Analyst– Mr. O’Neil was a Fellow at the Penn Center for Innovation, reflecting our commitment to mentoring innovation and entrepreneurship in the life sciences.

In addition to new hires across our strategy and investment banking teams, Back Bay Life Science Advisors marked several team promotions this year, including:

  • Vasilios M. Kofitsas to Managing Director, Financial Advisory

  • Jonathan Barry, MD, to Engagement Manager

  • Brendan Wang to Senior Consultant

  • Christian Thienel to Senior Consultant

  • Hannah Cabot to Associate

  • Yechan Kang to Consultant

  • Leah Strickling to Consultant

“Robust innovation in the life sciences is the result of global collaboration that increasingly requires an array of expertise and creative thinking,” said Back Bay CEO, Jonathan P. Gertler, MD.“Back Bay teams think creatively and have the training and experience to back it up with data and synthesize creativity into compelling strategies that contribute immensely to the global life science industry. For more than ten years, we have nurtured the best life science experts. I am incredibly proud of the people at Back Bay,” said Dr. Gertler.

About Back Bay Life Science Advisors

Back Bay Life Science Advisors guide biotech, pharmaceutical, and medical technology companies and their investors on development, commercialization, growth, and maintenance of market share, providing clear and unbiased advice and execution for the critical decisions that drive value.Back Bay works with companies of all sizes across the U.S. and global life science markets at every stage, sector, geography, and in every therapeutic area. We bring to light the value of new technologies, medicines, and scientific approaches to position assets for maximum value and impact.From planning and initial concept to product commercialization, franchising, and licensing, and continuing through M&A and divestiture, Back Bay Life Science Advisors help shape the life science industry.Connect with Back Bay Life Science Advisors at www.bblsa.com.

Sign up for our newsletter:bblsa.com/news-resources/LinkedIn:back-bay-life-science-advisors

Jocelyn Miller